Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit

Descripción del Articulo

Objective: to establish the discriminative capacity of the Finnish risk score for dysglycemia in users of a family medicine unit located in the suburbs of the State of Guerrero, Mexico. Material and methods: We conducted a cross-sectional study from March to December 2021 in a Family Medicine Unit....

Descripción completa

Detalles Bibliográficos
Autores: García-Morales, Gabriela, Casarrubias-Martínez, Miriam, Herrera-Reyes, Víctor F, García-Jiménez, Yuliana, Rosaliano-Salinas, Josue
Formato: artículo
Fecha de Publicación:2023
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/2618
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/2618
Nivel de acceso:acceso abierto
Materia:Risk Assessment
Diabetes Mellitus
Screening
Area Under Curve
id REVCMP_9aaa42d0e662296f2509e56f316b6184
oai_identifier_str oai:ojs.pkp.sfu.ca:article/2618
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling Finnish risk score for detection of dysglycemia in adults in the Family Medicine UnitPuntaje de riesgo finlandés para detección de disglucemia en adultos en Unidad de Medicina FamiliarGarcía-Morales, GabrielaCasarrubias-Martínez, MiriamHerrera-Reyes, Víctor FGarcía-Jiménez, YulianaRosaliano-Salinas, JosueRisk AssessmentDiabetes MellitusScreeningArea Under CurveObjective: to establish the discriminative capacity of the Finnish risk score for dysglycemia in users of a family medicine unit located in the suburbs of the State of Guerrero, Mexico. Material and methods: We conducted a cross-sectional study from March to December 2021 in a Family Medicine Unit. With prior informed consent, we applied the Finnish risk score for the detection of dysglycemia to 200 people between the ages of 20 and 60, we obtained somatometric measurements and fasting plasma glucose figures. We estimated sensitivity, specificity, positive and negative predictive value, positive and negative likelihood ratio, and calculated the area under the curve (AUC) to estimate the discriminative ability of the risk score, where the reference test was fasting glucose. We performed bivariate analysis to identify factors associated with dysglycemia, obtaining Odds Ratio (OR) and 95% confidence intervals (95%CI). Result: The occurrence of dysglycemia was 26.5% (53/200). The AUC of the ROC curve of the Finnish score for dysglycemia was 0.65 (95%CI 0.57-0.74). The factors associated with diabetes were ≥40 years (OR 2.1; 95%CI 1.1-3.9), body mass index ≥25 Kg/m2 (OR 2.8; 95%CI 1.2-6.7) and suffering from arterial hypertension (OR 2.2; 95%CI 1.1 -4.4). Conclusions: The FINDRISC was shown by AUC to be a poor tool for detecting people at risk of suffering from dysglycemia, in a population attached to a suburban medical unitObjetivo: establecer la capacidad discriminativa del puntaje de riesgo finlandés para disglucemia en usuarios de una unidad de medicina familiar localizada en zona conurbana del Estado de Guerrero, México. Material y métodos: Realizamos un estudio transversal de marzo a diciembre del 2021 en una Unidad de Medicina Familiar. Previo consentimiento informado aplicamos a 200 personas de 20 a 60 años, el puntaje de riesgo finlandés para detección de disglucemia, obtuvimos medidas somatométricas y cifras de glucosa plasmática en ayuno. Estimamos sensibilidad, especificidad, valor predictivo positivo y negativo, razón de verosimilitud positiva y negativa, y calculamos el área bajo la curva (AUC) para estimar la capacidad discriminativa del puntaje de riesgo, donde la prueba de referencia fue la glucosa en ayuno. Realizamos análisis bivariado para identificar factores asociados a disglucemia, obteniendo Odds Ratio (OR), e intervalos de confianza del 95 % (IC95%). Resultado: La ocurrencia de disglucemia fue de 26.5 % (53/200). El AUC de la curva ROC del puntaje finlandés para disglucemia fue de 0.65 (IC95% 0.57-0.74). Los factores asociados a diabetes fueron ≥40 años (OR 2.1; IC95% 1.1-3.9), índice de masa corporal ≥25 Kg/m2 (OR 2.8; IC95% 1.2-6.7) y padecer hipertensión arterial (OR 2.2; IC95% 1.1-4.4). Conclusiones: El FINDRISC demostró por AUC ser una mala herramienta para detectar personas en riesgo de padecer disglucemia, en población adscrita a unidad médica conurbana.Colegio Médico del Perú2023-10-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmltext/xmlhttps://amp.cmp.org.pe/index.php/AMP/article/view/261810.35663/amp.2023.403.2618ACTA MEDICA PERUANA; Vol 40 No 3 (2023): July - SeptemberACTA MEDICA PERUANA; Vol. 40 Núm. 3 (2023): Julio - Setiembre1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2618/1565https://amp.cmp.org.pe/index.php/AMP/article/view/2618/1703https://amp.cmp.org.pe/index.php/AMP/article/view/2618/1704Copyright (c) 2023 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/26182024-10-02T03:58:58Z
dc.title.none.fl_str_mv Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit
Puntaje de riesgo finlandés para detección de disglucemia en adultos en Unidad de Medicina Familiar
title Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit
spellingShingle Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit
García-Morales, Gabriela
Risk Assessment
Diabetes Mellitus
Screening
Area Under Curve
title_short Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit
title_full Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit
title_fullStr Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit
title_full_unstemmed Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit
title_sort Finnish risk score for detection of dysglycemia in adults in the Family Medicine Unit
dc.creator.none.fl_str_mv García-Morales, Gabriela
Casarrubias-Martínez, Miriam
Herrera-Reyes, Víctor F
García-Jiménez, Yuliana
Rosaliano-Salinas, Josue
author García-Morales, Gabriela
author_facet García-Morales, Gabriela
Casarrubias-Martínez, Miriam
Herrera-Reyes, Víctor F
García-Jiménez, Yuliana
Rosaliano-Salinas, Josue
author_role author
author2 Casarrubias-Martínez, Miriam
Herrera-Reyes, Víctor F
García-Jiménez, Yuliana
Rosaliano-Salinas, Josue
author2_role author
author
author
author
dc.subject.none.fl_str_mv Risk Assessment
Diabetes Mellitus
Screening
Area Under Curve
topic Risk Assessment
Diabetes Mellitus
Screening
Area Under Curve
description Objective: to establish the discriminative capacity of the Finnish risk score for dysglycemia in users of a family medicine unit located in the suburbs of the State of Guerrero, Mexico. Material and methods: We conducted a cross-sectional study from March to December 2021 in a Family Medicine Unit. With prior informed consent, we applied the Finnish risk score for the detection of dysglycemia to 200 people between the ages of 20 and 60, we obtained somatometric measurements and fasting plasma glucose figures. We estimated sensitivity, specificity, positive and negative predictive value, positive and negative likelihood ratio, and calculated the area under the curve (AUC) to estimate the discriminative ability of the risk score, where the reference test was fasting glucose. We performed bivariate analysis to identify factors associated with dysglycemia, obtaining Odds Ratio (OR) and 95% confidence intervals (95%CI). Result: The occurrence of dysglycemia was 26.5% (53/200). The AUC of the ROC curve of the Finnish score for dysglycemia was 0.65 (95%CI 0.57-0.74). The factors associated with diabetes were ≥40 years (OR 2.1; 95%CI 1.1-3.9), body mass index ≥25 Kg/m2 (OR 2.8; 95%CI 1.2-6.7) and suffering from arterial hypertension (OR 2.2; 95%CI 1.1 -4.4). Conclusions: The FINDRISC was shown by AUC to be a poor tool for detecting people at risk of suffering from dysglycemia, in a population attached to a suburban medical unit
publishDate 2023
dc.date.none.fl_str_mv 2023-10-30
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2618
10.35663/amp.2023.403.2618
url https://amp.cmp.org.pe/index.php/AMP/article/view/2618
identifier_str_mv 10.35663/amp.2023.403.2618
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2618/1565
https://amp.cmp.org.pe/index.php/AMP/article/view/2618/1703
https://amp.cmp.org.pe/index.php/AMP/article/view/2618/1704
dc.rights.none.fl_str_mv Copyright (c) 2023 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
text/xml
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 40 No 3 (2023): July - September
ACTA MEDICA PERUANA; Vol. 40 Núm. 3 (2023): Julio - Setiembre
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075112857731072
score 13.986012
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).